Form 4: Elanco CEO Buys $478K in Company Stock

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, purchased 22,000 shares of common stock for approximately $478,495 on December 11, 2025.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN), acquired 22,000 shares of the company's common stock.
• The transaction occurred on December 11, 2025, at a weighted average price of $21.7498 per share.
• The total value of the purchase was approximately $478,495.60.
• This acquisition was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.
• Following this transaction, Simmons beneficially owns 167,000 shares indirectly through a revocable trust and 1,802,380 shares directly.
• The direct ownership includes 1 share acquired on April 30, 2025, under the Elanco Animal Health Inc.'s Employee Stock Purchase Plan.

Sentiment

Score: 7

Explanation: The CEO's significant purchase of company stock indicates strong insider confidence, which is generally a positive signal for investors.

Positives

• The CEO's purchase of 22,000 shares demonstrates strong insider confidence in the company's future prospects.
• The transaction was executed under a Rule 10b5-1 plan, which provides transparency and indicates a pre-planned investment strategy, mitigating concerns about trading on non-public information.

Stakeholder Impact

• Shareholders: May view the CEO's stock purchase as a positive signal of confidence in the company's future performance, potentially influencing investor sentiment and stock price.

Key Dates

Recommendation

The significant stock purchase by the CEO, Jeffrey N. Simmons, signals strong insider confidence in Elanco Animal Health Inc.'s future. This action, often seen as a bullish indicator, suggests management believes the stock is undervalued or poised for growth. While this is a positive development, a 'hold' recommendation is prudent without a comprehensive review of the company's broader financial health, market position, and industry trends. It reinforces a positive outlook for existing shareholders and could be a factor for those considering an investment.

Keywords

Elanco Animal Health, ELAN, Insider Trading, Stock Purchase, CEO, Jeffrey N. Simmons, Form 4, Equity Acquisition, Rule 10b5-1